SOX9 was reported to activate Wnt/β‐catenin pathway and drive the tumour progression in non‐small‐cell lung cancer.19 Hence, we explored the interaction between SOX9 and Wnt/β‐catenin pathway in GBM. Here, SOX9 is linked to neoplasm.